Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 2 |
2016 | 2 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19.
N Engl J Med. 2020.
PMID: 32955177
Clinical Trial.
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; ALEX Trial Investigators.
Peters S, et al.
N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6.
N Engl J Med. 2017.
PMID: 28586279
Free article.
Clinical Trial.
Item in Clipboard
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators.
Tsuboi M, et al.
N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4.
N Engl J Med. 2023.
PMID: 37272535
Clinical Trial.
Item in Clipboard
[Possibilities of local hyperthermia in treatment for edematous breast cancer patients].
Kurpeshev OK, Ragulin YA, Mozerov SA, Orlova AV, Lebedeva TV.
Kurpeshev OK, et al. Among authors: ragulin ya.
Vopr Onkol. 2016;62(5):680-687.
Vopr Onkol. 2016.
PMID: 30695598
Review.
Russian.
Item in Clipboard
[Pulmonary metastases: classification and the need for staging?].
Smolenov EI, Ragulin YA, Pikin OV, Ryabov A.
Smolenov EI, et al. Among authors: ragulin ya.
Khirurgiia (Mosk). 2018;(3. Vyp. 2):22-26. doi: 10.17116/hirurgia20183222-26.
Khirurgiia (Mosk). 2018.
PMID: 29652318
Russian.
Item in Clipboard
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses.
Mitchell P, Thatcher N, Socinski MA, Wasilewska-Tesluk E, Horwood K, Szczesna A, Martín C, Ragulin Y, Zukin M, Helwig C, Falk M, Butts C, Shepherd FA.
Mitchell P, et al. Among authors: ragulin y.
Ann Oncol. 2015 Jun;26(6):1134-1142. doi: 10.1093/annonc/mdv104. Epub 2015 Feb 26.
Ann Oncol. 2015.
PMID: 25722382
Free article.
Clinical Trial.
Item in Clipboard
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial.
Schuler M, Yang JC, Park K, Kim JH, Bennouna J, Chen YM, Chouaid C, De Marinis F, Feng JF, Grossi F, Kim DW, Liu X, Lu S, Strausz J, Vinnyk Y, Wiewrodt R, Zhou C, Wang B, Chand VK, Planchard D; LUX-Lung 5 Investigators.
Schuler M, et al.
Ann Oncol. 2016 Mar;27(3):417-23. doi: 10.1093/annonc/mdv597. Epub 2015 Dec 8.
Ann Oncol. 2016.
PMID: 26646759
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite